Vinyl Chemicals Q2 FY27: standalone PAT up 4x YoY to ₹11.4 Cr, revenue +44%
PAT +296.2% YoY · revenue +43.9% · margins expanding
₹218.57 Cr
+43.9% YoY
₹11.41 Cr
+296.2% YoY
5.25%
+3.4pp YoY
₹6.24
Vinyl Chemicals (India) reported standalone revenue from operations of ₹218.57 Cr for Q2 FY27, up 43.9% YoY from ₹151.89 Cr, with PAT of ₹11.41 Cr versus ₹2.88 Cr a year ago (+296%) and NPM expanding to 5.25% from 1.88%. Part of the YoY jump is a low-base effect — Q2 FY26 PAT had itself fallen sharply from the prior year — so the step-change overstates the underlying run-rate even though both revenue and PAT grew together this quarter, unlike a pure base-effect bounce.
Q2 FY-2027 vs prior quarters
Sequentially the picture is more moderate: revenue rose 119.4% QoQ but PAT only 72.4%, so NPM compressed from Q1 FY27's 6.25% to 5.25%. That's mainly a trading-cost-timing effect — Q1's margin was flattered by a large inventory build-up that temporarily held down cost of goods sold in the P&L, while Q2 saw inventories drawn down, pulling the cost line back up. A ₹1.76 Cr forex gain embedded within expenses (versus a ₹1.64 Cr forex expense a year ago) also aided the quarter, while "other income" turned negative at -₹1.24 Cr (versus +₹1.27 Cr YoY), a modest non-operating drag likely tied to investment mark-to-market.
The stock went into the print at ₹240.07, up 8.5% over the past month of trading.
For context: this is the highest quarterly PAT in the last 6 quarters on our records; PAT has now risen for 4 consecutive quarters; revenue is at a 6-quarter high.
What the summary numbers don't show
EPS basic ₹6.24 for the quarter (not annualised) vs ₹1.58 YoY and ₹3.61 QoQ
There is no prior management guidance or concall commentary on record to grade this print against, and no management press release beyond the routine stock-exchange intimation — both are explicitly absent rather than simply unaddressed. A web check found no analyst or consensus estimates for this micro-cap trading company (Simply Wall St notes no analyst forecasts exist for the stock), so there is no street bar to compare against either. Notably, H1 FY27 PAT of ₹18.03 Cr has already surpassed full-year FY26 PAT of ₹16.50 Cr.
W1
Whether the ₹1.76 Cr forex gain and -₹1.24 Cr other income swing (both embedded in this quarter's P&L) reverse or normalize next quarter
W2
Whether NPM holds near 5.25% or reverts toward FY26's full-year 2.49% level now that H1 FY27 PAT (₹18.03 Cr) has already overtaken FY26's full-year PAT (₹16.50 Cr)
W3
Working-capital trajectory — inventories (₹91.30 Cr) and trade payables (₹140.08 Cr) built up sharply this quarter and will need to unwind or stabilize
Standalone only — company has no subsidiaries/associates/JVs (filing note 2); single reportable segment (trading in chemicals); no exceptional items in any period shown; other income and the forex line (embedded in expenses) are volatile swing items quarter to quarter.